Premera Launches Fresh Takeda Antitrust Suit Over IBS Drug
By Hailey Konnath · November 30, 2023, 10:10 PM EST
A Blue Cross affiliate has once again lodged a proposed class action against Takeda Pharmaceuticals over an alleged conspiracy to keep generic versions of the drug Amitiza off the market, filing...
To view the full article, register now.